Molecular Diagnostics Market Research Report
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
List of Figures<br />
69. Evolution of Sequencing for <strong>Molecular</strong> <strong>Diagnostics</strong><br />
70. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Sequencing), 2017-2028<br />
71. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Microarray), 2017-2028<br />
72. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by ISH),<br />
2017-2028<br />
73. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by IHC),<br />
2017-2028<br />
74. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by NAA),<br />
2017-2028<br />
75. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Isothermal<br />
Amplification), 2017-2028<br />
76. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Other<br />
Technologies), 2017-2028<br />
77. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by End-User)<br />
78. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by End-User),<br />
2017 and 2028<br />
79. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Hospitals),<br />
2017-2028<br />
80. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Diagnostic<br />
Centers), 2017-2028<br />
81. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Out-Patient<br />
Clinics/GPs), 2017-2028<br />
82. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by <strong>Research</strong><br />
Laboratories), 2017-2028<br />
83. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Region),<br />
2017 and 2028<br />
84. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Region),<br />
2017-2028<br />
85. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> Share (by<br />
Region), 2017<br />
86. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> Share (by<br />
Region), 2028<br />
87. North America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-<br />
2028<br />
88. North America: <strong>Market</strong> Dynamics<br />
89. North America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Country), 2017-2028<br />
90. The U.S. <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
91. Canada <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
92. Overview of Reimbursement Policies in Europe<br />
(Focus on Companion <strong>Diagnostics</strong> as well)<br />
93. Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
94. Europe: <strong>Market</strong> Dynamics<br />
95. Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Country),<br />
2017-2028<br />
96. Germany <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
97. France <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
98. Italy <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
99. The U.K. <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
100. Spain <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
101. The Netherlands <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>,<br />
2017-2028<br />
102. Rest-of-Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-<br />
2028<br />
103. Asia-Pacific <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-<br />
2028<br />
104. APAC: <strong>Market</strong> Dynamics<br />
105. APAC <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Country),<br />
2017-2028<br />
106. Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
107. China <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
108. India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
109. Australia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
110. Singapore <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
111. RoAPAC <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
112. Latin America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-<br />
2028<br />
113. Latin America: <strong>Market</strong> Dynamics<br />
114. Latin America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Country), 2017-2028<br />
115. Brazil <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
116. Mexico <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
117. Rest-of-Latin America <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>,<br />
2017-2028<br />
118. RoW <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, 2017-2028<br />
sales@bisresearch.com | www.bisresearch.com
Change language